Cardiomyopathy, Hypertrophic Clinical Trial
Official title:
Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy
DDD pacing improves symptoms and relieves LV outflow tract (LVOT) obstruction in most patients with hypertrophic cardiomyopathy (HCM). Notably, when pacing is temporarily discontinued, the beneficial effects of pacing are evident in sinus rhythm. The long term results of this novel therapy are, however, uncertain. We propose (1) to record the hemodynamic changes following >4 years of pacing; and (2) to determine whether DDD pacing continues to be necessary in patients who have had a substantial relief of their LVOT obstruction. Patients who have had >50% reduction in LVOT pressure gradients will be randomized to two pacing modalities: DDD at 70 beats per minute and AAI pacing at 70 beats per minute (DDD switched off), and reevaluated after a six-month period.
DDD pacing improves symptoms and relieves LV outflow tract (LVOT) obstruction in most patients with hypertrophic cardiomyopathy (HCM). Notably, when pacing is temporarily discontinued, the beneficial effects of pacing are evident in sinus rhythm. The long term results of this novel therapy are, however, uncertain. We propose (1) to record the hemodynamic changes following >4 years of pacing; and (2) to determine whether DDD pacing continues to be necessary in patients who have had a substantial relief of their LVOT obstruction. Patients who have had >50% reduction in LVOT pressure gradients will be randomized to two pacing modalities: DDD at 70 beats per minute and AAI pacing at 70 beats per minute (DDD switched off), and reevaluated after a six-month period. ;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00253682 -
Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers
|
N/A | |
Recruiting |
NCT06034405 -
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
|
||
Terminated |
NCT04222101 -
Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy
|
N/A | |
Recruiting |
NCT05646056 -
A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
|
||
Completed |
NCT00692991 -
Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
|
N/A | |
Withdrawn |
NCT04905173 -
Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy
|
N/A | |
Recruiting |
NCT03251287 -
Nitrite in Hypertrophic Cardiomyopathy (HCM) Study
|
Phase 1 | |
Recruiting |
NCT01165749 -
Exercise Study Including Patients With Hypertrophic Cardiomyopathy
|
N/A | |
Recruiting |
NCT03057002 -
UTSW HP [13-C] Pyruvate Injection in HCM
|
||
Recruiting |
NCT02696135 -
The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
|
||
Recruiting |
NCT03040947 -
MRI Sequence and Imaging Protocol Development
|
||
Active, not recruiting |
NCT02417311 -
Individualized Early Risk Assessment for Heart Diseases
|
||
Completed |
NCT03225001 -
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve
|
N/A | |
Recruiting |
NCT05524077 -
Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
|
N/A | |
Completed |
NCT04164732 -
Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy
|
Phase 2 | |
Recruiting |
NCT06112743 -
A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
|
Phase 4 | |
Completed |
NCT00001871 -
Study of Muscle Abnormalities in Patients With Specific Genetic Mutations
|
N/A | |
Completed |
NCT00001459 -
Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers
|
N/A | |
Completed |
NCT00005251 -
Genetic Analysis of Familial Hypertrophic Cardiomyopathy
|
N/A | |
Active, not recruiting |
NCT05556343 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
|
Phase 2 |